Matches in Wikidata for { <http://www.wikidata.org/entity/Q92439103> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q92439103 description "article scientifique publié en 2019" @default.
- Q92439103 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92439103 description "scientific article published on 05 August 2019" @default.
- Q92439103 description "wetenschappelijk artikel" @default.
- Q92439103 description "наукова стаття, опублікована 5 серпня 2019" @default.
- Q92439103 name "A drug-drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokinetics" @default.
- Q92439103 name "A drug-drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokinetics" @default.
- Q92439103 type Item @default.
- Q92439103 label "A drug-drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokinetics" @default.
- Q92439103 label "A drug-drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokinetics" @default.
- Q92439103 prefLabel "A drug-drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokinetics" @default.
- Q92439103 prefLabel "A drug-drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokinetics" @default.
- Q92439103 P1433 Q92439103-4ACD986D-1C52-4986-BB09-B1D8145570D7 @default.
- Q92439103 P1476 Q92439103-83C15B29-E32B-42F1-8C3F-414E9824AB58 @default.
- Q92439103 P2093 Q92439103-14A3DCA2-C415-4582-8F50-523C5856709D @default.
- Q92439103 P2093 Q92439103-22B19709-D524-4B37-A935-33A3D07363AF @default.
- Q92439103 P2093 Q92439103-7D26735C-27AE-4FAA-B543-3562BD878E01 @default.
- Q92439103 P2093 Q92439103-CA235193-55CF-47E1-99DB-988B77FAD795 @default.
- Q92439103 P2093 Q92439103-D0765B11-6471-48CC-BA65-7F194D4E5D07 @default.
- Q92439103 P2860 Q92439103-0F82DB2B-FDD9-45E0-A4B7-A155BFB13258 @default.
- Q92439103 P2860 Q92439103-1616954F-AE5C-4393-B5CF-8E9355433C97 @default.
- Q92439103 P2860 Q92439103-1EAB7A58-9552-48A6-9554-3593F7864FD2 @default.
- Q92439103 P2860 Q92439103-28FC904F-67DB-46BA-9F3C-7BE6E8C7D611 @default.
- Q92439103 P2860 Q92439103-4DF3AFE9-8E90-4D1E-920A-C6EC44574C48 @default.
- Q92439103 P2860 Q92439103-550EBAA9-1CA4-4561-91B6-C44830E05A16 @default.
- Q92439103 P2860 Q92439103-67DDDB81-A7BC-4501-9D9C-833DDD46C667 @default.
- Q92439103 P2860 Q92439103-7180F6D3-63B5-49D2-B636-A9971BE9B75C @default.
- Q92439103 P2860 Q92439103-7382A931-0D04-4767-BA23-713C01C12D9D @default.
- Q92439103 P2860 Q92439103-80D528B7-3F07-4023-B597-30AAEFBE152F @default.
- Q92439103 P2860 Q92439103-A3BFC752-A6FB-406B-B8C2-DE6DF4FACC29 @default.
- Q92439103 P2860 Q92439103-CC2784E0-6EC2-43AA-9B64-182811BF1EFF @default.
- Q92439103 P2860 Q92439103-CC5E9245-D95B-4053-BCDE-362D85EC9A3D @default.
- Q92439103 P2860 Q92439103-F6918ACE-D9FB-4AFC-83EA-654842CFF501 @default.
- Q92439103 P2860 Q92439103-F88C49DF-08BB-4EE8-AA60-BDCFCDE81649 @default.
- Q92439103 P304 Q92439103-2886FB68-3380-4D5C-9E7A-98B2F99F1B4E @default.
- Q92439103 P31 Q92439103-93A16584-3738-4145-839F-2CA94765FF2C @default.
- Q92439103 P356 Q92439103-2903E414-94B3-401D-B245-FE9CAD0BC477 @default.
- Q92439103 P433 Q92439103-B332F5B3-0667-4033-9DED-3B1915E26A94 @default.
- Q92439103 P478 Q92439103-67B68843-1225-4F83-82F3-432663B0773D @default.
- Q92439103 P577 Q92439103-E58A7610-B9D8-4798-9D59-D6585ED92047 @default.
- Q92439103 P698 Q92439103-2E7FC80C-BC6F-4F30-830A-8FD354F6BA9F @default.
- Q92439103 P921 Q92439103-70845A7E-AED5-451F-BB64-B3297DEAF172 @default.
- Q92439103 P921 Q92439103-BF388F8C-B1A8-4075-8739-F3C87A93626F @default.
- Q92439103 P932 Q92439103-E42DDBDE-962E-4AD4-B449-4EA3246C6DB8 @default.
- Q92439103 P356 S00280-019-03915-1 @default.
- Q92439103 P698 31385001 @default.
- Q92439103 P1433 Q326137 @default.
- Q92439103 P1476 "A drug-drug interaction study to assess the potential effect of acid-reducing agent, lansoprazole, on quizartinib pharmacokinetics" @default.
- Q92439103 P2093 "Denise Trone" @default.
- Q92439103 P2093 "Jeanne Mendell" @default.
- Q92439103 P2093 "Jianke Li" @default.
- Q92439103 P2093 "Natalie Cook" @default.
- Q92439103 P2093 "Patrick O'Donnell" @default.
- Q92439103 P2860 Q26776396 @default.
- Q92439103 P2860 Q28267442 @default.
- Q92439103 P2860 Q34517403 @default.
- Q92439103 P2860 Q36416358 @default.
- Q92439103 P2860 Q37244802 @default.
- Q92439103 P2860 Q38614998 @default.
- Q92439103 P2860 Q38667491 @default.
- Q92439103 P2860 Q39013343 @default.
- Q92439103 P2860 Q42770379 @default.
- Q92439103 P2860 Q43055360 @default.
- Q92439103 P2860 Q45977770 @default.
- Q92439103 P2860 Q46255450 @default.
- Q92439103 P2860 Q46909869 @default.
- Q92439103 P2860 Q53587222 @default.
- Q92439103 P2860 Q73913252 @default.
- Q92439103 P304 "799-807" @default.
- Q92439103 P31 Q13442814 @default.
- Q92439103 P356 "10.1007/S00280-019-03915-1" @default.
- Q92439103 P433 "4" @default.
- Q92439103 P478 "84" @default.
- Q92439103 P577 "2019-08-05T00:00:00Z" @default.
- Q92439103 P698 "31385001" @default.
- Q92439103 P921 Q323936 @default.
- Q92439103 P921 Q718753 @default.
- Q92439103 P932 "6768889" @default.